1 Min Read
May 30 (Reuters) - Sierra Oncology Inc
* Sierra Oncology granted U.S. and EU patents for CHK1 inhibitor SRA737 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.